Nieuws

The National Institute for Health and Care Excellence1d

Final decision on cerliponase alfa for Batten disease treatment confirmed

In final draft guidance published today we've confirmed that we’re unable to recommend cerliponase alfa (also called Brineura and made by BioMarin) for routine NHS use in treating neuronal ceroid ...